PEPG Insider Trading

Insider Ownership Percentage: 4.60%
Insider Buying (Last 12 Months): $27,219,853.50
Insider Selling (Last 12 Months): $143,120.00

PepGen Insider Trading History Chart

This chart shows the insider buying and selling history at PepGen by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

PepGen Share Price & Price History

Current Price: $17.39
Price Change: Price Increase of +0.14 (0.81%)
As of 06/17/2024 12:48 PM ET

This chart shows the closing price history over time for PEPG up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

PepGen Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/11/2024Michelle L. MellioninsiderSell500$18.04$9,020.00View SEC Filing Icon  
5/17/2024Niels SvenstrupSVPSell10,000$13.41$134,100.00View SEC Filing Icon  
2/9/2024Ra Capital Management, L.P.DirectorBuy2,557,593$10.64$27,212,789.529,179,273View SEC Filing Icon  
11/30/2023James G McarthurCEOBuy1,694$4.17$7,063.981,694View SEC Filing Icon  
6/7/2023James G. McarthurCEOSell8,419$16.23$136,640.37View SEC Filing Icon  
6/5/2023James G. McarthurCEOSell500$16.06$8,030.00View SEC Filing Icon  
6/2/2023James G. McarthurCEOSell1,800$16.04$28,872.00View SEC Filing Icon  
3/24/2023Jaya GoyalEVPSell392$20.00$7,840.00View SEC Filing Icon  
2/8/2023Jaya GoyalEVPSell644$17.00$10,948.00View SEC Filing Icon  
2/6/2023Jaya GoyalEVPSell1,677$17.04$28,576.08View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for PepGen (NASDAQ:PEPG)

58.01% of PepGen stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PEPG by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

PepGen Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/17/2024RA Capital Management L.P.10,689,545$157.14M2.0%+31.5%32.972%Search for SEC Filing on Google Icon
5/17/2024Artal Group S.A.200,000$2.94M0.1%N/A0.617%Search for SEC Filing on Google Icon
5/16/2024Janus Henderson Group PLC1,166,642$17.23M0.0%+18.1%3.602%Search for SEC Filing on Google Icon
5/10/2024Acadian Asset Management LLC2,052$30K0.0%N/A0.006%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.850,445$12.50M0.0%+68.0%2.626%Search for SEC Filing on Google Icon
11/15/2023Adage Capital Partners GP L.L.C.680,000$3.45M0.0%+18.3%2.856%Search for SEC Filing on Google Icon
11/13/2023Rathbones Group PLC62,003$0.32M0.0%N/A0.260%Search for SEC Filing on Google Icon
11/13/2023FMR LLC2,365,965$12.02M0.0%-13.8%9.937%Search for SEC Filing on Google Icon
10/27/2023Allspring Global Investments Holdings LLC6,564$33K0.0%N/A0.028%Search for SEC Filing on Google Icon
10/24/2023Bank of New York Mellon Corp31,398$0.16M0.0%-15.0%0.132%Search for SEC Filing on Google Icon
8/15/2023Suvretta Capital Management LLC486,611$4.35M0.2%-41.2%2.044%Search for SEC Filing on Google Icon
8/4/2023American International Group Inc.4,837$43K0.0%-33.3%0.020%Search for SEC Filing on Google Icon
8/2/2023Bank of Montreal Can199,532$2.66M0.0%N/A0.839%Search for SEC Filing on Google Icon
3/23/2023MetLife Investment Management LLC8,647$0.12M0.0%N/A0.037%Search for SEC Filing on Google Icon
11/15/2022Parkman Healthcare Partners LLC100,000$0.91M0.3%N/A0.423%Search for SEC Filing on Google Icon
11/14/2022Tudor Investment Corp Et Al220,530$1.57M0.0%-24.2%0.933%Search for SEC Filing on Google Icon
11/14/2022Altium Capital Management LP40,000$0.36M0.1%-50.0%0.169%Search for SEC Filing on Google Icon
8/16/2022Deerfield Management Company L.P. Series C953,626$9.47M0.2%N/A4.036%Search for SEC Filing on Google Icon
8/15/2022Laurion Capital Management LP664,516$6.60M0.1%N/A2.812%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
PepGen logo
PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. Its lead product candidate is PGN-EDO51, an EDO peptide that is in Phase 2 clinical trial to treat Duchenne muscular dystrophy (DMD) patients. The company is also developing PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 1 clinical trial for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. PepGen Inc. was founded in 2018 and is based in Boston, Massachusetts.
Read More on PepGen

Today's Range

Now: $17.39
Low: $16.79
High: $17.55

50 Day Range

MA: $14.08
Low: $10.53
High: $18.14

52 Week Range

Now: $17.39
Low: $3.72
High: $18.38

Volume

12,306 shs

Average Volume

100,078 shs

Market Capitalization

$563.78 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.76

Who are the company insiders with the largest holdings of PepGen?

PepGen's top insider shareholders include:
  1. Ra Capital Management, LP (Director)
  2. James G Mcarthur (CEO)
  3. James G Mcarthur (CEO)
  4. Jaya Goyal (EVP)
  5. Michelle L Mellion (Insider)
  6. Niels Svenstrup (SVP)
Learn More about top insider investors at PepGen.

Who are the major institutional investors of PepGen?

PepGen's top institutional investors include:
  1. RA Capital Management L.P. — 32.97%
  2. Janus Henderson Group PLC — 3.60%
  3. Vanguard Group Inc. — 2.63%
  4. Artal Group S.A. — 0.62%
  5. Acadian Asset Management LLC — 0.01%
Learn More about top institutional investors of PepGen stock.

Which major investors are buying PepGen stock?

During the previous quarter, PEPG stock was bought by institutional investors including:
  1. RA Capital Management L.P.
  2. Vanguard Group Inc.
  3. Artal Group S.A.
  4. Janus Henderson Group PLC
  5. Acadian Asset Management LLC
During the previous year, these company insiders have bought PepGen stock:
  1. Ra Capital Management, LP (Director)
  2. James G Mcarthur (CEO)
Learn More investors buying PepGen stock.